1.94
1.94 (-5.33%)
As of Mar 06, 2024
Cue Biopharma, Inc. [CUE]
Source:
Company Overview
Cue Biopharma, Inc is a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted, disease relevant T cells directly within the patient’s body. Our vision is to translate nature's cues into protein therapeutics by generating a new class of T cell engagers for selective modulation of disease specific T cells.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | 617-949-2680 |
Industry | manufacturing |
CEO | Daniel R. Passeri |
Website | www.cuebiopharma.com |